Taipei, Taiwan

Cheng-Chiao Huang


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Cheng-Chiao Huang: Innovator in Cancer Detection and Treatment

Introduction

Cheng-Chiao Huang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research through his innovative work on antibodies. His research focuses on the development of anti-EGF like domain multiple 6 (EGFL6) antibodies, which play a crucial role in cancer detection and treatment.

Latest Patents

Cheng-Chiao Huang holds a patent for the invention titled "Anti-EGF like domain multiple 6 (EGFL6) antibodies." This invention relates to the creation of anti-EGFL6 antibodies, particularly single-chain antibody fragments (scFv) and humanized antibodies. These antibodies have the ability to bind to EGFL6, inhibiting angiogenesis and cancer cell growth. His work is pivotal in advancing cancer diagnosis and therapeutic strategies.

Career Highlights

Throughout his career, Cheng-Chiao Huang has been associated with notable institutions such as Taipei Medical University and Changhua Christian Medical Foundation Changhua Christian Hospital. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

Cheng-Chiao Huang has worked alongside esteemed colleagues, including Yu-Ching Lee and Shiow-Lin Pan. Their collaborative efforts have further enhanced the impact of his research in the medical community.

Conclusion

Cheng-Chiao Huang's innovative work in developing anti-EGFL6 antibodies represents a significant advancement in cancer detection and treatment. His contributions to the field continue to inspire future research and development in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…